Scilex Holding Company is a biopharmaceutical company focused on developing and commercializing innovative pain management therapies

The company leverages advanced science and technology to create novel medical solutions aimed at improving the quality of life for patients suffering from acute and chronic pain conditions. With a commitment to addressing unmet medical needs, Scilex prioritizes the development of safe and effective therapeutic options, contributing to the evolving landscape of pain management in healthcare.